COSTEM 2019 | Unrelated transplantation vs. immunosuppression for SAA

Name: Unrelated transplantation vs. immunosuppression for SAA
Uploaded: 2019-10-25T00:00:00.000Z
Duration: 2 min 29 s
Description: Antonio Risitano, MD, PhD, University of Naples Federico II, Naples, Italy, discusses whether the use of unrelated transplantation is more efficacious than standard immunosuppression for severe aplastic anemia (SAA). This interview took place at the 5th International Congress on Controversies in Stem Cell Transplantation and Cellular Therapies (COSTEM) 2019, held in Berlin, Germany.

Antonio Risitano • 25 Oct 2019

COSTEM 2019

Anemias Aplastic Anemia Cyclosporine

Antonio Risitano, MD, PhD, University of Naples Federico II, Naples, Italy, discusses whether the use of unrelated transplantation is more efficacious than standard immunosuppression for severe aplastic anemia (SAA). This interview took place at the 5th International Congress on Controversies in Stem Cell Transplantation and Cellular Therapies (COSTEM) 2019, held in Berlin, Germany.